Too Early To The Cannabis ETF Party?
On the latest episode of Let's Talk ETFs, we take a look at the Amplify Seymour Alternative Plant Economy ETF (CNBS). CNBS' manager, Tim Seymour, who also hosts CNBC Fast Money lays out the long-term bullish case for this sector while trying to make sense of its terrible performance YTD. We want to wish a Happy Thanksgiving to all of our listeners! Topics include: 2:00 - Tim's backstory: What drew him to cannabis investing? 13:00 - Launching the Amplify Seymour Cannabis ETF, and Tim's Fast Money platform. 20:00 - After so much carnage in the space, are Cannabis sector valuations finally more reasonable? 27:30 - What did prognosticators like Deloitte get wrong in the lead-up to legalization in Canada and California? 37:30 - How does Tim get access to US markets via CNBS and when does he see investors being able to profit from markets beyond Canada? 50:45 - How is CNBS structured and how does Tim value stocks in the space? 1:01:00 - Effect of Bruce Linton firing on Canopy Growth Corporation (CGC). 1:09:45 - Which companies are best positioned for global growth? (ACB) 1:15:30 - Stock recommendation: MediPharm Labs (OTCQX:MEDIF) [TSE:LABS] 1:17:30 - Concluding remarks: Where's the industry headed? Learn more about your ad choices. Visit megaphone.fm/adchoices
